Natasha Persaud

Adjuvant platinum-based chemotherapy for upper tract urothelial carcinoma within 90-days of nephroureterectomy improves disease-free and metastasis-free survival compared with surveillance, a study found.

In a study, 8.8% of clinically relevant prostate cancers detected by systematic biopsy were missed by MRI-targeted biopsy.

Less intensive PSA screening in men with low PSA levels can substantially reduce unnecessary testing, according to investigators.

Type of surgical approach to radical prostatectomy—robot-assisted vs open procedure—is not associated with a patient’s intermediate-term decision regret, according to a recent study.

In a long-term follow-up of the CheckMate trial, investigators observed consistently prolonged survival with nivolumab compared with everolimus.

In a study, metastasectomy was associated with significantly longer median progression-free and overall survival in some mRCC patients.

Bone metastases less predictive in the setting of cytoreductive nephrectomy.

In a study of men with prostate cancer, the presence of pre-existing cardiovascular diseases was associated with higher risk of death from taking certain medications.

A study found that patients with more advanced-stage upper tract urothelial carcinoma had a higher prevalence of lymph node metastasis.

In a study, localized prostate cancer patients reported clinically meaningful differences in urinary, bowel, sexual, and hormonal function by management option up to 5 years of follow-up.